FranΓ§aisπ See the interactive version (live chart) β
For Danaher Corporation, we replayed every analyst price target of the past 12 months and measured the real outcome: 45% were profitable, average return +12% (208 calls). At 3 months: +3% average return (37% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Barclays | 33 | 36% | +7% |
| Citigroup | 17 | 71% | +27% |
| RBC Capital | 16 | 31% | +4% |
| Baird | 14 | 21% | +3% |
| Morgan Stanley | 12 | 83% | +26% |
Is Danaher Corporation overvalued, and is it a good time to buy Danaher Corporation right now? If you're wondering, here's a recap to make up your own mind: Danaher Corporation's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Danaher Corporation | Sector median (Health Care) |
|---|---|---|
| P/E | 38.4 | 29.4 |
| Forward P/E | 23.2 | 17.1 |
| Net margin | 16% | 12% |
π Danaher Corporation trades above its sector median (38.4 vs 29.4) β the market expects higher growth; watch out for disappointment.
π P/E, PEG, marginβ¦: see the glossary
π΅ Dividend : Danaher Corporation pays about $1.44/share/yr β 0.74% yield. what is this?
The analyst consensus on Danaher Corporation (DHR) is "Buy" (24 bullish, 0 bearish calls over 12 months). This is not advice: historically, 45% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $230 (+7% vs $216), ranging from $95.00 to $255 (14 analysts).
Over 1 year, 45% of analyst targets on Danaher Corporation were profitable, for an average return of +12% (across 208 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $230 within 12 months, i.e. +7% vs the current price. The most bullish targets $255, the most cautious $95.00.
Note: analyst targets are 12-month (median $230, +7%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (45%), and the stock's past trajectory.
Its P/E is 38.4, forward P/E 23.2. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of Danaher Corporation β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.